Skip to main content

Market Overview

70 Biggest Movers From Yesterday

70 Biggest Movers From Yesterday



  • Arvinas, Inc. (NASDAQ: ARVN) shares climbed 95.1% to close at $58.38 on Monday after the company reported interim clinical data for its cancer treatment. The company said ARV-471 showed evidence of anti-tumor activity.
  • BioCardia, Inc. (NASDAQ: BCDA) shares climbed 58.9% to close at $4.48. BioCardia said it expects data safety monitoring board verbal feedback for interim data from Phase 3 CardiaAMP heart failure trial by the end of December 15, 2020.
  • Veru Inc. (NASDAQ: VERU) shares gained 52.6% to close at $9.69. Veru reported Phase 2 trial results for enobosarm for endocrine resistant metastatic breast cancer.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) jumped 36.6% to close at $8.73 after declining around 17% on Friday.
  • AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) rose 35.1% to close at $5.70 after the company said it made significant progress in detecting pre-cancer diseases.
  • GasLog Partners LP (NYSE: GLOP) surged 31.2% to close at $3.45.
  • Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) gained 29.4% to close at $15.20.
  • Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares surged 29.2% to close at $156.31 after AstraZeneca plc (NASDAQ: AZN) announced plans buy the company for $39 billion.
  • CooTek (Cayman) Inc. (NYSE: CTK) rose 28.4% to close at $6.33. CooTek released quarterly earnings today.
  • Teligent, Inc. (NASDAQ: TLGT) gained 28.2% to close at $0.8085 after declining over 8% on Friday. A Special Meeting of Stockholders is scheduled to reconvene on Wednesday December 16.
  • BioLineRx Ltd. (NASDAQ: BLRX) rose 27% to close at $3.39.
  • Humanigen, Inc. (NASDAQ: HGEN) gained 26.3% to close at $11.96.
  • ReneSola Ltd (NYSE: SOL) shares jumped 26% to close at $6.98. HC Wainwright & Co. maintained ReneSola with a Buy and raised the price target from $4 to $12.
  • Mid-Con Energy Partners, LP (NASDAQ: MCEP) surged 25.6% to close at $3.78.
  • Evelo Biosciences, Inc. (NASDAQ: EVLO) gained 24.8% to close at $9.41 after jumping around 18% on Friday. Evelo Biosciences, last week, reported new clinical candidate in oncology.
  • Arbutus Biopharma Corporation (NASDAQ: ABUS) surged 24.8% to close at $4.88. Arbutus Biopharma, last week, announced additional clinical data from an ongoing Phase 1a/1b clinical trial with AB-729.
  • Chinook Therapeutics, Inc. (NASDAQ: KDNY) climbed 23.1% to close at $16.40. Chinook Therapeutics reported a license agreement with Morehouse School of Medicine for development of therapies in kidney diseases disproportionately affecting African Americans and underserved communities.
  • Graybug Vision, Inc. (NASDAQ: GRAY) gained 22.6% to close at $22.81.
  • Nurix Therapeutics, Inc. (NASDAQ: NRIX) shares climbed 22% to close at $48.44.
  • DermTech, Inc. (NASDAQ: DMTK) shares climbed 21.4% to close at $13.95. DermTech, on Friday, announced Inclusion of its melanoma test in two continuing medical education sessions at 2020 Fall Clinical Virtual Grand Rounds and Mount Sinai Winter Symposium.
  • Domo, Inc. (NASDAQ: DOMO) gained 20.8% to close at $56.43
  • Summit Wireless Technologies, Inc. (NASDAQ: WISA) jumped 20.3% to close at $3.14 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $3.5 price target.
  • Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) gained 20.1% to close at $41.53.
  • O2Micro International Limited (NASDAQ: OIIM) shares rose 18.1% to close at $7.57.
  • Centrus Energy Corp. (NYSE: LEU) gained 17.9% to close at $20.98.
  • Catalyst Biosciences, Inc. (NASDAQ: CBIO) surged 17.6% to close at $7.29. Catalyst Biosciences, last week, presented Crimson 1 Phase 3 study design at the 62nd Annual American Society of Hematology Conference.
  • Calix, Inc. (NASDAQ: CALX) gained 17.2% to close at $29.06. Arlo, last week, announced a strategic partnership with Calix.
  • Homology Medicines, Inc. (NASDAQ: FIXX) jumped 17% to close at $11.97.
  • Prelude Therapeutics Incorporated (NASDAQ: PRLD) gained 17% to close at $72.67.
  • Marathon Patent Group, Inc. (NASDAQ: MARA) shares rose 16.6% to close at $5.54 after declining 9% on Friday. HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $7.5 to $9. Marathon Patent Group last week purchased additional 10K S-19j Pro ASIC miners from Bitmain and announced plans to open a second data center.
  • Sterling Construction Company, Inc. (NASDAQ: STRL) gained 16.5% to close at $19.30.
  • Vince Holding Corp. (NYSE: VNCE) shares rose 16.3% to close at $6.98 after the company reported completion of third lien credit facility. Vince said it projects preliminary Q3 sales of $69 million.
  • Gatos Silver, Inc. (NYSE: GATO) shares climbed 16.1% to close at $8.73. Gatos Silver reported quarterly results last week.
  • Recro Pharma, Inc. (NASDAQ: REPH) rose 16.1% to close at $3.43 after climbing around 37% on Friday.
  • BioVie Inc. (NASDAQ: BIVI) gained 15.9% to close at $12.00.
  • Social Capital Hedosophia Holdings Corp. II (NASDAQ: IPOB) gained 15.9% to close at $29.48.
  • Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares gained 14.8% to close at $11.65.
  • Prothena Corporation plc (NASDAQ: PRTA) surged 14% to close at $12.73.
  • Synlogic Inc (NASDAQ: SYBX) shares rose 13.4% to close at $2.54 after the company announced plans to advance its cancer treatment into the combination therapy stage of its phase 1 trial.
  • Atomera Incorporated (NASDAQ: ATOM) gained 10.9% to close at $12.00.
  • C4 Therapeutics, Inc. (NASDAQ: CCCC) rose 10.8% to close at $32.15.
  • Inseego Corp. (NASDAQ: INSG) gained 10.2% to close at $15.16 after climbing 12% on Friday. The company on Thursday announced its 5G MiFi M2000 mobile hotspot is now available at T-Mobile and on Friday announced the availability of 5G MiFi M200 in Japan.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) gained 8.8% to close at $52.05. Apellis and Sobi last week reported top-lone results at 48 weeks from Phase 3 PEGASUS study of pegcetacoplan in PNH.
  • Aligos Therapeutics, Inc. (NASDAQ: ALGS) rose 7.6% to close at $23.80.
  • 22nd Century Group, Inc. (NYSE: XXII) fell 7.5% to close at $2.35 after climbing 18% on Friday.
  • Socket Mobile, Inc. (NASDAQ: SCKT) gained 7.5% to close at $2.86 after the company announced it received a notice of forgiveness from Western Alliance Bank for the $1.06 million PPP loan.
  • Prevail Therapeutics Inc. (NASDAQ: PRVL) gained 7% to close at $12.50. Prevail Therapeutics, last week, said first patient was dosed in Phase 1/2 PROCLAIM trial evaluating PR006 for the treatment of frontotemporal dementia patients with GRN mutations.
  • Pluralsight, Inc. (NASDAQ: PS) rose 6.4% to close at $20.19 after the company agreed to be acquired by private-equity firm Vista Equity Partners in an all-cash transaction for $20.26 per share..
  • GoHealth, Inc. (NASDAQ: GOCO) rose 6% to close at $14.09.


Check out these big penny stock gainers and losers


  • Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) shares tumbled 46.7% to close at $1.20 on Monday after the company disclosed results from its phase 2 trial of Razuprotafib glaucoma. HC Wainwright & Co. maintained Aerpio Pharmaceuticals with a Neutral and lowered the price target from $2 to $1.5.
  • Fossil Group, Inc. (NASDAQ: FOSL) fell 27.4% to close at $9.65.
  • SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) dropped 20.1% to close at $6.69. SELLAS Life Sciences Group shares tumbled around 53% on Friday after the company reported follow-up data from a randomized Phase 2 VADIS trial of Nelipepimut-S in woman with ductal carcinoma in-situ of the breast.
  • Titan International, Inc. (NYSE: TWI) fell 19.7% to close at $4.21.
  • AMC Entertainment Holdings, Inc. (NYSE: AMC) dipped 18.6% to close at $3.19.
  • Virgin Galactic Holdings, Inc. (NASDAQ: SPCE) shares dipped 17.4% to close at $26.46. A test flight of the VSS Unity from Virgin Galactic returned home early after an ignition failure on Saturday.
  • SolarWinds Corporation (NYSE: SWI) declined 16.7% to close at $19.62 after the company said some of its products may have been affected by a highly sophisticated hack.
  • Eargo, Inc. (NASDAQ: EAR) dipped 16.7% to close at $47.47.
  • Greenwich LifeSciences, Inc. (NASDAQ: GLSI) fell 16.4% to close at $46.80 after declining over 22% on Friday. Greenwich LifeSciences last week shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.
  • TechTarget, Inc. (NASDAQ: TTGT) dropped 16.4% to close at $50.31 after the company reported a proposed offering of convertible senior notes.
  • IEC Electronics Corp. (NASDAQ: IEC) fell 15.5% to close at $10.50.
  • NextDecade Corporation (NASDAQ: NEXT) dipped 15.1% to close at $2.93 after climbing 38% on Friday.
  • AbCellera Biologics Inc. (NASDAQ: ABCL) fell 15.1% to close at $50.01.
  • Immutep Limited (NASDAQ: IMMP) fell 14.3% to close at $2.99 after declining over 38% on Friday. Immutep last week reported a statistically significant survival benefit for key patient groups in its ongoing Phase IIb AIPAC study in metastatic breast cancer.
  • Destination XL Group, Inc. (NASDAQ: DXLG) declined 14.1% to close at $0.2702 after the company announced it would delist from the Nasdaq.
  • Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares declined 13.4% to close at $7.79. Vivos Therapeutics shares climbed around 50% on Friday after the company priced its IPO at $6 per share..
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) declined 11.8% to close at $2.01. Xenetic Biosciences, last week, announced a roughly 2.45 million shares registered direct offering priced at $2.45 per share.
  • Team, Inc. (NYSE: TISI) fell 10.4% to close at $9.96.
  • Fusion Fuel Green PLC (NASDAQ: HTOO) fell 9.9% to close at $17.75.
  • Gamida Cell Ltd (NASDAQ: GMDA) shares fell 8.4% to close at $9.09 after the company pushed back its timeline to submit a biologics license application from 2020 to 2H 2021 due to additional data requests from the Food and Drug Administration.
  • AstraZeneca PLC (NYSE: AZN) fell 7.8% to close at $50.03 after the company announced it would acquire Alexion Pharmaceuticals for $39 billion in cash and stock.

Related Articles (ABUS + ABCL)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at